EGF and lung cancer: Figure 3A,B show that treatment with 100 μM AvnA or AvnC caused an increase in the number of dead cells, both in basal conditions and in EGF-treated cells, indicating that Avns reduce the capability of lung cancer cells to survive in anchorage-independent conditions and inhibit the EGF activity.